Fed Pullback Pledge...
Health Care: Drugs
Corcept Therapeutics Inc. (CORT: NASDAQ)
$1.79 -0.04 | -2.19%
06/19/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -38.05M | -32.35M | -25.97M | -20.17M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -557.00K | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | -4.66M | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 193.00K | 2.79M | -453.00K | -34.00K |
| (Decrease) Increase In Other Current Liabilities | 474.00K | -1.63M | 1.90M | -280.00K |
| (Increase) Decrease In Other Working Capital | 27.00K | 72.00K | -23.00K | -30.00K |
| Other Non-Cash Items | 5.31M | 3.44M | 2.12M | 1.82M |
| Net Cash From Continuing Operations | -36.02M | -27.40M | -22.28M | -17.97M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -36.02M | -27.40M | -22.28M | -17.97M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 3.59M |
| Purchases of Property, Plant & Equipment | -151.00K | -25.00K | 0.00 | 0.00 |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -151.00K | -25.00K | 0.00 | 3.59M |
| Issuance of Debt | 29.86M | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 59.71M | 42.48M | 23.00M | 23.54M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | -6.00K | -10.00K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 89.57M | 42.48M | 23.00M | 23.52M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 53.40M | 15.06M | 711.00K | 9.15M |
Portfolios with CORT
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
Latest CORT Headlines from TheStreet
- 5 Stocks Setting Up to Break Out 01.25.13 | 01:01 pm
- 3 Stocks Under $2 Spiking Higher 01.03.13 | 03:01 pm
- Short Sellers Are More Bullish About These Hedge Fund Favorites 12.20.12 | 04:12 pm
- 5 Stocks Insiders Are Snapping Up 11.28.12 | 12:11 pm
- Corcept Has Upside Following Drug Approval 02.21.12 | 12:02 pm
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- These Drugs Stocks Will Win FDA Approval 02.16.12 | 12:02 pm
- Biotech Stock Mailbag: Corcept Therapeutics, Reader Retorts 02.10.12 | 07:02 am
- Play TheStreet's FDA Drug-Approval Contest 01.23.12 | 08:01 am
- 27 Hot Drugs Facing FDA Approval in 2012 12.19.11 | 10:12 am
Press Releases for CORT
- Behind The Success - Research Report On Corcept Therapeutics Inc. And Dyax Corp. - PR Newswire 01.23.13 | 08:01 am
Partner Headlines for CORT
- 2 $2 Biotech Stocks Insiders Are Buying - Seeking Alpha 03.01.13 | 09:03 am
- 3 Liquid Biotech Stocks With Impressive Growth Projections - Seeking Alpha 08.12.12 | 09:08 am
- Facebook and Nasdaq STILL BATTLING and 3 Headlines Investors are Watching Now - Wall St. Cheat Sheet 07.02.12 | 12:07 pm
- Company News for February 22, 2012 - Corporate Summary - Zacks 02.22.12 | 10:02 am
- UPDATE: Stifel Nicolaus Increases Target to $9 on Concept Therepeutics - Benzinga 02.21.12 | 09:02 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
- 14 Oversold Stocks With Bearish Options - Seeking Alpha 07.01.11 | 08:07 am
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
